Surmontil (Teva Women’s Health, Inc.)


Welcome to the PulseAid listing for the Surmontil drug offered from Teva Women’s Health, Inc.. This Tricyclic Antidepressant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Women’s Health, Inc.
NON-PROPRIETARY NAME: Trimipramine Maleate
SUBSTANCE NAME: TRIMIPRAMINE MALEATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Tricyclic Antidepressant [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00


Surmontil HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSurmontil from Teva Women’s Health, Inc.
LABELER NAME: Teva Women’s Health, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51285-538_2cd02db6-835a-4795-852e-aa6e6d263124
PRODUCT NDC: 51285-538
APPLICATION NUMBER: NDA016792

Other TRIMIPRAMINE MALEATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Trimipramine Maleate
Breckenridge Pharmaceutical, Inc.Trimipramine Maleate
Dr. Reddy Laboratories, Inc.Trimipramine Maleate
Teva Women’s Health, Inc.Surmontil